Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,233,356
+$742,551 QoQ
Shares Held
115,267
+159.3% QoQ
Ownership
0.581%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 132 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Derivatives in KROS
reported options exposure · as of Mar 31, 2026CallValue
$131,376
CallShares
11,900
PutValue
$298,080
PutShares
27,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. KROS ranks #77 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in KROS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,233,356 | 115,267 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $131,376 | 11,900 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $298,080 | 27,000 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $490,805 | 44,457 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $659,664 | 32,400 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $3,298,501 | 162,009 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,338,372 | 84,600 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $2,570,037 | 162,455 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $1,028,300 | 65,000 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $1,520,565 | 113,900 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $1,509,885 | 113,100 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $764,701 | 57,281 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,389,916 | 136,400 | Put | Defined | 2025-05-19 | |
| 2025-03-31 | $544,146 | 53,400 | Call | Defined | 2025-05-19 | |
| 2025-03-31 | $478,368 | 46,945 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,600,601 | 101,112 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $8,065,385 | 509,500 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $978,294 | 61,800 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $534,244 | 9,200 | Call | Defined | 2024-11-15 | |
| 2024-09-30 | $3,494,536 | 60,178 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $2,051,792 | 44,897 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $1,282,889 | 19,379 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $772,018 | 19,417 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $338,119 | 10,606 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $504,901 | 12,566 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $813,093 | 19,042 | Shares | Defined | 2023-05-16 | |
| 2022-06-30 | $921,625 | 33,356 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $1,424,756 | 26,200 | Call | Defined | 2022-05-17 | |
| 2020-06-30 | $389,990 | 10,397 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||